ANXA1-mediated mTOR/FABP4 Inhibition Drives Antifibrotic Macrophage Reprogramming in Lupus Nephritis
Year: 2026
Type: article
Abstract: macrophages in renal fibrosis progression, offering novel therapeutic targets for LN.
DOI: 10.7150/ijbs.118613
Authors: Juan Tao, Qingyu Cheng, Pinjie Zhang, Guizhen Yu, Qi Chen, Manwen Yang, Qiqin Wu, Haopeng Fang, Haibo Wu, Xiaoyuan Song, Zhu Chen, Min Chen, Xiaoming Meng, Mingxing Lei, Tengchuan Jin
Institutions: University of Science and Technology of China, Chinese Academy of Sciences, Peking University Shenzhen Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Peking University First Hospital, Anhui Medical University, Chongqing University
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,337
OpenAlex ID: W7128926415
FWCI:
Cites:
Cited by:
Related to:
